Urodynamix Technologies Ltd.
TSX VENTURE : URO

Urodynamix Technologies Ltd.

April 02, 2009 09:00 ET

Urodynamix Expands Asian Distribution of URO NIRS 2000

VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 2, 2009) - Urodynamix Technologies Ltd. (TSX VENTURE:URO) announced that it has entered into a distribution agreement with Suntek Medical Systems ("Suntek"), a leading distributor of urology products in South Korea. The agreement grants Suntek non-exclusive sales, marketing and distribution rights for the URO NIRS 2000 Bladder Monitor technology in Korea.

In conjunction with the distribution agreement, Suntek placed an initial stocking order of $73,500 US. The URO NIRS 2000 will be marketed in South Korea upon receipt of Korean Food and Drug Administration ("KFDA") registration for the product which is expected to be completed in mid 2009. Suntek will register the URO NIRS 2000 for approval with KFDA.

Suntek is a privately held company based in Seoul, South Korea with over 20 years experience introducing and marketing urology products throughout South Korea. Suntek's extensive expertise in urology includes relationships such as MedTronic, American Medical Systems Inc., Laborie Medical Technologies Inc. and Olympus's Gyrus ACMI.

"Our non-invasive URO NIRS 2000 technology has the potential to change the diagnosis of urinary conditions globally and Suntek has an outstanding reputation for introducing products and working with key opinion leaders in South Korea," said Barry Allen, CEO of Urodynamix. "Suntek has the proven ability to effectively register and market our technology. The addition of this strong regional distributor is part of a strategy to enhance our existing worldwide distribution agreements."

"Suntek has been a leader in urodynamics and our sales force is looking forward to introducing and promoting this exciting new technology," said Chong Young Park, President of Suntek. "This new technology will help provide a faster and more flexible approach to bladder monitoring."

About Suntek.

Suntek is a leader in the field of urology product distribution, having been involved in marketing urology products throughout Korea since 1989. Suntek's key areas of product distribution include urology, lithotripsy, andrology, OB/GYN and surgical products. The main corporate office of Suntek is located in Seoul, South Korea and they have 3 branch offices located throughout South Korea to support a direct and dealer sales network.

About Urodynamix Technologies Ltd.

Urodynamix Technologies Ltd. is a Canadian medical device company developing and commercializing non-invasive medical technology based on proprietary applications of near-infrared spectroscopy (NIRS). The Company is currently focused on products that aid in the diagnosis and treatment of urinary incontinence, lower urinary tract symptoms, prostate cancer, benign prostatic hyperplasia, and traumatic increases in intra-abdominal pressure that cause abdominal compartment syndrome. Urodynamix's breakthrough medical technology has the potential to beneficially affect more than 200 million people worldwide.

Certain information contained in this press release may be forward-looking and is subject to unknown risks, which could cause actual results to differ materially from those set forth or implied herein. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information